A critical review of the SAFE strategy for the prevention of blinding trachoma

Lancet Infectious Diseases

Volumn 3, Issue 6, 2003, Pages 372-381

  Kuper, Hannah ^a   Solomon, Anthony W ^a   Buchan, John ^a   Zondervan, Marcia ^a   Foster, Allen ^a   Mabey, David ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE TRANSMISSION; ENVIRONMENTAL SANITATION; EYE DISEASE; HEALTH EDUCATION; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TRACHOMA; BLINDNESS; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED MEDICINE; HYGIENE; INFECTION CONTROL; ORGANIZATION AND MANAGEMENT; WATER MANAGEMENT; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; BLINDNESS; CHLAMYDIA TRACHOMATIS; COMMUNICABLE DISEASE CONTROL; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; ENVIRONMENTAL EXPOSURE; EVIDENCE-BASED MEDICINE; HUMANS; HYGIENE; TRACHOMA; WATER PURIFICATION; WORLD HEALTH ORGANIZATION;

EID: 0037527539     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(03)00659-5     Document Type: Review

References (103)

1. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ 1995; 73:115-21.
2. Collier LH, Duke-Elder S, Jones BR. Experimental trachoma produced by cultured virus. Br J Ophthalmol 1958; 42: 705-20.
3. Report of the fifth meeting of the WHO alliance for the global elimination of trachoma (WHO/PBD/GET/00.10). Geneva: World Health Organization, 2001.
4. West SK, Munoz B, Turner VM, Mmbaga BB, Taylor HR. The epidemiology of trachoma in central Tanzania. Int J Epidemiol 1991;20:1088-92.
5. Grayston JT, Wang SP, Yeh LJ, Kuo CC. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 1985; 7: 717-25.
6. MacCallan AF. The epidemiology of trachoma. Br J Ophthalmol 1931; 15: 369-411.
7. World Health Organization. Expert committee on trachoma third report. World Health Organ Tech Rep Ser 1962; 234: 1-48.
8. Dawson CR, Jones BR, Darougar S. Blinding and non-blinding trachoma: assessment of intensity of upper tarsal inflammatory disease and disabling lesions. Bull World Health Organ 1975; 52: 279-82.
9. Dawson CR, Jones BR, Tarizzo ML. Guide to trachoma control in programmes for the prevention of blindness. Geneva: World Health Organization, 1981.
10. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987; 65: 477-83.
11. Taylor HR, West SK, Katala S, Foster A. Trachoma: evaluation of a new grading scheme in the United Republic of Tanzania. Bull World Health Organ 1987;65:485-88.
12. Schachter J. Chlamydia trachomatis: the more you look, the more you find - how much is there? Sex Transm Dis 1998; 25: 229-31.
13. Mabey D, Holland M, Solomon A, et al. The epidemiology of ocular Chlamydia trachomatis infection in a trachoma endemic community determined by quantitative PCR. Proceedings of the 10th international symposium on human chlamydial infections; June 16-21 2002; Antalya, Turkey.
14. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet 1999; 354: 630-35.
15. Holm SO, Jha HC, Bhatta RC, et al. Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. Bull World Health Organ 2001; 79: 194-200.
16. Baral K, Osaki S, Shreshta B, et al. Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal. Bull World Health Organ 1999; 77: 461-66.
17. Hadgu A. The discrepancy in discrepant analysis. Lancet 1996; 348: 592-93.
18. McAdam AJ. Discrepant analysis: how can we test a test? J Clin Microbiol 2000; 38: 2027-29.
19. Schachter J, Stamm WE, Quinn TC. Discrepant analysis and screening for Chlamydia trachomatis. Lancet 1996; 348: 1308-09.
20. Hadgu A. Discrepant analysis: a biased and an unscientific method for estimating test sensitivity and specificity. J Clin Epidemiol 1999; 52: 1231-37.
21. West SK, Rapoza P, Munoz B, Katala S, Taylor HR. Epidemiology of ocular chlamydial infection in a trachoma-hyperendemic area. J Infect Dis 1991; 163: 752-56.
22. Taylor HR, Rapoza PA, West S, et al. The epidemiology of infection in trachoma. Invest Ophthalmol Vis Sci 1989; 30: 1823-33.
23. Dawson C, Munoz B, Shama A, et al. Antibiotic treatment of trachoma in the Egyptian arm of the ACT trial: laboratory testing and clinical examinations. In: Schachter J, Christiansen G, Clarke IN, et al, eds. Chlamydial infections: Proceedings of the 10th international symposium on human chlamydial infections. June 16-21, 2002; Antalya, Turkey.
24. West S, Lynch M, Munoz B, Katala S, Tobin S, Mmbaga BB. Predicting surgical compliance in a cohort of women with trichiasis. Int Ophthalmol 1994;18:105-09.
25. Bowman RJ, Jatta B, Faal H, Bailey R, Foster A, Johnson GJ. Long-term follow-up of lid surgery for trichiasis in the Gambia: surgical success and patient perceptions. Eye 2000; 14: 864-68.
26. Reacher MH, Munoz B, Alghassany A, Daar AS, Elbualy M, Taylor HR. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol 1992; 110: 667-74.
27. Bowman RJ, Jatta B, Cham B, et al. Natural history of trachomatous scarring in The Gambia: results of a 12-year longitudinal follow-up. Ophthalmology 2001; 108: 2219-24.
28. Sullivan JH. The use of cryotherapy for trichiasis. Trans Am Acad Ophthalmol Otolaryngol 1977; 83: 708-12.
29. Babalola OE. Correction of trachomatous entropion/trichiasis in Kaduna: an assessment of two simplified methods. East Afr Med J 1988; 65: 525-31.
30. Khandekar R, Mohammed AJ, Courtright P. Recurrence of trichiasis: a long-term follow-up study in the Sultanate of Ornan. Ophthalmic Epidemiol 2001; 8: 155-61.
31. Unlu K, Aksunger A, Soker S, Karaca C, Bilek K. Prospective evaluation of the argon laser treatment of trachomatous trichiasis. Jpn J Ophthalmol 2000; 44: 677-79.
32. Rice CD, Kersten RC, al-Hazzaa S. Cryotherapy for trichiasis in trachoma. Arch Ophthalmol 1989; 107: 1180-82.
33. Peart DA, Hill JC. Cryosurgery for trichiasis in black patients. Br J Ophthalmol 1986; 70: 712-4.
34. Reacher MH, Taylor HR. The management of trachomatous trichiasis. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique 1990; 67: 233-62.
35. Fox S. Cicatricial entropion of the upper lid. Am J Ophthalmol 1964; 57: 379-82.
36. Jones BR, Barras TC, Hunter PA, Darougar S. Neglected lid deformities causing progressive corneal disease. Surgical correction of entropion, trichiasis, marginal keratinization, and functional lid shortening. Trans Ophthalmol Soc UK 1976; 96: 45-51.
37. Ballen PH. A simple procedure for the relief of trichiasis and entropion of the upper lid. Arch Ophthalmol 1964; 72: 239-240.
38. Reacher M, Foster A, Huber J. Trichiasis surgery for trachoma: the bilamellar tarsal rotation procedure (WHO/PBL/93,29). Geneva: World Health Organization, 1993.
39. Bowman RJ, Soma OS, Alexander N, et al. Should trichiasis surgery be offered in the village? A community randomised trial of village vs. health centre-based surgery. Trop Med Int Health 2000; 5: 528-33.
40. Bog H, Yorston D, Foster A. Results of community-based eyelid surgery for trichiasis due to trachoma. Br J Ophthalmol 1993; 77: 81-83.
41. Halasa AH, Jarudi N. Tarsotomy for the correction of cicatricial entropion. Ann Ophthalmol 1974; 6: 837-40.
42. Adamu Y, Alemayehu W. A randomized clinical trial of the success rates of bilamellar tarsal rotation and tarsotomy for upper eyelid trachomatous trichiasis. Ethiop Med J 2002; 40: 107-14.
43. Trabut G. Entropion-Trichiasis en Afrique du Nord. Arch d'Ophthalmol NS 1949: 701-07.
44. Ndoye PA, Ngom A, Ndiaye CS, et al. Trachomatous entropion trichiasis at the ophthalmologic clinic of Dantec CHU (apropos of 199 cases). Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique 1997; 74: 97-106.
45. Courtright P. Acceptance of surgery for trichiasis among rural Malawian women. East Afr Med J 1994; 71: 803-04.
46. Oliva MS, Munoz B, Lynch M, Mkocha H, West SK. Evaluation of barriers to surgical compliance in the treatment of trichiasis. Int Ophthalmol 1997; 21: 235-41.
47. Mabey D, Fraser-Hurt N. Antibiotics for trachoma (Cochrane Review). Cochrane Database Syst Rev 2002 (1): CD001860.
48. Freyche MJ. Antibiotics and sulfonamides in the treatment of trachoma. Bull World Health Organ 1950; 2: 523-44.
49. Thylefors B. Development of trachoma control programs and the involvement of national resources. Rev Infect Dis 1985; 7: 774-76.
50. Daghfous T, Dawson CR, Messadi M, Hoshiwara I, Vastine D. Comparative study of the effect of rifampicin, of tetracycline and of a placebo in the treatment of trachoma. Rev Int Trach 1974; 51: 71-80.
51. Dawson CR, Daghfous T, Messadi M, et al. Microbiologic findings in a controlled trial of rifampicin and tetracycline for the treatment of severe endemic trachoma in Tunisia. Rev Int Trach 1974 51: 59-69.
52. Whitcher JP, Dawson CR, Messadi M, et al. Severe endemic trachoma in Tunisia: changes in ocular bacterial pathogens in children treated by the intermittent antibiotic regimen. Rev Int Trach 1974; 51: 49-58.
53. Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 1993; 342: 453-56.
54. Tabbara KF, Abu-el-Asrar A, al-Omar O, Choudhury AH, al-Faisal Z. Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study. Ophthalmology 1996;103:842-46.
55. Dawson CR, Schachter J, Sallam S, Sheta A, Rubinstein RA, Washton H. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis 1997; 24: 363-68.
56. Bowman RJ, Sillah A, Van Dehn C, et al. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci 2000; 41: 4074-79.
57. Hanna L, Dawson CR, Briones O, Thygeson P, Jawetz E. Latency in human infections with TRIC agents. J Immunol 1968; 101: 43-50.
58. Bailey RL, Hampton TJ, Hayes LJ, Ward ME, Whittle HC, Mabey DC. Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communities. J Infect Dis 1994; 170: 709-12.
59. Ward M, Bailey R, Lesley A, Kajbaf M, Robertson J, Mabey D. Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia. Scand J Infect Dis Suppl 1990; 69: 137-48.
60. Leach AJ, Shelby-James TM, Mayo M, et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis 1997; 24: 356-62.
61. Laming AC, Currie BJ, DiFrancesco M, Taylor HR, Mathews JD. A targeted, single-dose azithromycin strategy for trachoma. Med J Aust 2000; 172: 163-66.
62. Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med 1999; 5:572-76.
63. Taylor HR, Velasco FM, Sommer A. The ecology of trachoma: an epidemiological study in southern Mexico. Bull World Health Organ 1985; 63: 559-67.
64. Tielsch JM, West KP, Jr., Katz J, et al. The epidemiology of trachoma in southern Malawi. Am J Trop Med Hyg 1988; 38: 393-99.
65. Taylor HR, West SK, Mmbaga BB, et al. Hygiene factors and increased risk of trachoma in central Tanzania. Arch Ophthalmol 1989; 107: 1821-25.
66. West SK, Congdon N, Katala S, Mele L. Facial cleanliness and risk of trachoma in families. Arch Ophthalmol 1991; 109: 855-57.
67. West SK, Munoz B, Lynch M, Kayongoya A, Mmbaga BB, Taylor HR. Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. Am J Epidemiol 1996; 143: 73-78.
68. Guraksin A, Gullulu G. Prevalence of trachoma in eastern Turkey. Int J 1997; 26: 436-42.
69. Hsieh YH, Bobo LD, Quinn TO, West SK. Risk factors for trachoma: 6-year follow-up of children aged 1 and 2 years. Am J Epidemiol 2000; 152: 204-11.
70. Schemann JF, Sacko D, Malvy D, et al. Risk factors for trachoma in Mali. Int J Epidemiol 2002; 31: 194-201.
71. West S, Munoz B, Lynch M, et al. Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet 1995; 345: 155-58.
72. Lynch M, West SK, Munoz B, Kayongoya A, Taylor HR, Mmbaga BB. Testing a participatory strategy to change hygiene behaviour: face washing in central Tanzania. Trans R Soc Trop Med Hyg 1994; 88: 513-17.
73. Marshall CL. The relationship between trachoma and piped water in a developing area. Arch Environ Health 1968; 17: 215-20.
74. Assaad FA, Maxwell-Lyons F, Sundaresan T. Use of local variations in trachoma endemicity in depicting interplay between socio-economic conditions and disease. Bull World Health Organ 1969;41:181-94.
75. Cairncross S, Cliff JL. Water use and health in Mueda, Mozambique. Trans R Sdc Trop Med Hyg 1987; 81: 51-54.
76. West S, Lynch M, Turner V, et al. Water availability and trachoma, Bull World Health Organ 1989; 67: 71-75.
77. Katz J, West KP, Jr, Khatry SK, et al. Prevalence and risk factors for trachoma in Sarlahi district, Nepal. Br J Ophthalmol 1996; 80:1037-41.
78. Hoechsmann A, Metcalfe N, Kanjaloti S, et al. Reduction of trachoma in the absence of antibiotic treatment: evidence from a population-based survey in Malawi. Ophthalmic Epidemiol 2001; 8: 145-53.
79. Cairncross S, Feachem R. Environmental health engineering in the tropics. 2nd edn. London: Wiley; 1993.
80. Kupka K, Nizetic B, Reinhards J. Sampling studies on the epidemiology and control of trachoma in southern Morocco. Bull World Health Organ 1968; 39: 547-66.
81. Luna EJ, Medina NH, Oliveira MB, et al. Epidemiology of trachoma in Bebedouro State of Sao Paulo, Brazil: prevalence and risk factors. Int J Epidemiol 1992; 21: 169-77.
82. Bailey R, Downes B, Downes R, Mabey D. Trachoma and water use; a case control study in a Gambian village. Trans R Soc Trop Med Hyg 1991; 85: 824-28.
83. Emerson PM, Lindsay SW, Walraven GE, et al. Effect of fly control on trachoma and diarrhoea. Lancet 1999; 353: 1401-433.
84. Emerson PM, Bailey RL, Mahdi OS, Walraven GE, Lindsay SW. Transmission ecology of the fly Musca sorbens, a putative vector of trachoma. Trans R Soc Trop Med Hyg 2000; 94: 28-32.
85. Jones BR. The prevention of blindness from trachoma. Trans Ophthalmol Soc UK 1975; 95:16-33.
86. Forsey T, Darougar S. Transmission of chlamydiae by the housefly. Br J Ophthalmol 1981; 65: 147-50.
87. Reinhards J, Weber A, Nizetic B, Kupka K, Maxwell-Lyons F. Studies in the epidemiology and control of seasonal conjunctivitis and trachoma in southern Morocco. Bull World Health Organ 1968; 39: 497-545.
88. Gupta CK, Gupta UC. Flies and mothers as modes of transmission of trachoma and associated bacterial conjunctivitis. J All India Ophthalmol Soc 1970; 18: 17-22.
89. Brechner RJ, West S, Lynch M. Trachoma and flies. Individual vs environmental risk factors. Arch Ophthalmol 1992; 110: 687-89.
90. da Cruz L, Dadour IR, McAllister I, Jackson A, Isaacs T. Seasonal variation in trachoma and bush flies in north-western Australian Aboriginal communities. Clin Experiment Ophthalmol 2002; 30: 80-83.
91. Tabbara KF, al-Omar OM. Trachoma in Saudi Arabia. Ophthalmic Epidemiol 1997; 4: 127-40.
92. Dobson R. New fly trap may reduce prevalence of blindness from trachoma. Bull World Health Organ 2000; 78: 1282.
93. Conroy RM, Elmore-Meegan M, Morley D. Fly traps made by Maasai children reduce trachoma prevalence: a controlled trial. Dublin: Royal College of Surgeons of Ireland, 2001.
94. Portney GL, Hoshiwara I. Prevalence of trachoma among Southwestern American Indian tribe. Am J Ophthalmol 1970; 70: 843-48.
95. Emerson PM, Bailey RL, Walraven GE, Lindsay SW. Human and other faeces as breeding media of the trachoma vector Musca sorbens. Med Vet Entomol 2001; 15: 314-20.
96. Courtright P, Sheppard J, Lane S, Sadek A, Schachter J, Dawson CR. Latrine ownership as a protective factor in inflammatory trachoma in Egypt. Br J Ophthalmol 1991; 75: 322-25.
97. Zerihun N. Trachoma in Jimma zone, south western Ethiopia. Trop Med Int Health 1997; 2: 1115-21.
98. Emerson PM, Lindsay SW, Walraven GE, Dibba SM, Lowe KO, Bailey RL. The Flies and Eyes Project Design and methods of a cluster-randomised intervention study to confirm the importance of flies as trachoma vectors in The Gambia and to test a sustainable method of fly control using pit latrines. Ophthalmic Epidemiol 2002; 9: 105-17.
99. De Sole G. Impact of cattle on the prevalence and severity of trachoma. Br J Ophthalmol 1987; 71: 873-76.
100. Sahlu T, Larson C. The prevalence and environmental risk factors for moderate and severe trachoma in southern Ethiopia. J Trop Med Hyg 1992; 95: 36-41.
101. Frick KD, Keuffel EL, Bowman RJ. Epidemiological, demographic, and economic analyses: measurement of the value of trichiasis surgery in The Gambia. Ophthalmic Epidemiol 2001; 8: 191-201.
102. Frick KD, Lietman TM, Holm SO, Jha HC, Chaudhary JS, Bhatta RC. Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. Bull World Health Organ 2001; 79: 201-07.
103. Evans TG, Ranson MK, Kyaw TA, Ko CK. Cost effectiveness and cost utility of preventing trachomatous visual impairment: lessons from 30 years of trachoma control in Burma. Br J Ophthalmol 1996; 80: 880-89.